Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.08 -0.52%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
Revenue Growth %: -1.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
Revenue Growth %: -1.8%
Join SI Premium – FREE
Pfizer (NYSE: PFE) Surges 8%, Merck (NYSE: MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVE Corp CEO to retire, successor named for August transition
- Datavault AI auditor BPM resigns effective immediately
- Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
